Selective targeting of cancer cells by copper ionophores: an overview

V Oliveri - Frontiers in molecular biosciences, 2022 - frontiersin.org
Conventional cancer therapies suffer from severe off-target effects because most of them
target critical facets of cells that are generally shared by all rapidly proliferating cells. The …

[HTML][HTML] Copper in cancer: from pathogenesis to therapy

D Guan, L Zhao, X Shi, X Ma, Z Chen - Biomedicine & Pharmacotherapy, 2023 - Elsevier
One of the basic trace elements for the structure and metabolism of human tissue is copper.
However, as a heavy metal, excessive intake or abnormal accumulation of copper in the …

Leveraging disulfiram to treat cancer: Mechanisms of action, delivery strategies, and treatment regimens

Y Lu, Q Pan, W Gao, Y Pu, K Luo, B He, Z Gu - Biomaterials, 2022 - Elsevier
Disulfiram (DSF) has been used as an alcoholism drug for 70 years. Recently, it has
attracted increasing attention owing to the distinguished anticancer activity, which can be …

Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment

Y Wang, DL Drum, R Sun, Y Zhang, F Chen… - Nature …, 2023 - nature.com
The poor efficacy of chimeric antigen receptor T-cell therapy (CAR T) for solid tumors is due
to insufficient CAR T cell tumor infiltration, in vivo expansion, persistence, and effector …

Disulfiram: a novel repurposed drug for cancer therapy

C Lu, X Li, Y Ren, X Zhang - Cancer chemotherapy and pharmacology, 2021 - Springer
Cancer is a major health issue worldwide and the global burden of cancer is expected to
reduce the costs of treatment as well as prolong the survival time. One of the promising …

ALDH and cancer stem cells: Pathways, challenges, and future directions in targeted therapy

K Lavudi, SM Nuguri, P Pandey, RR Kokkanti… - Life Sciences, 2024 - Elsevier
Human ALDH comprise 19 subfamilies in which ALDH1A1, ALDH1A3, ALDH3A1,
ALDH5A1, ALDH7A1, and ALDH18A1 are implicated in CSC. Studies have shown that …

Radiation‐induced immunogenic cell death for cancer radioimmunotherapy

T Liu, P Pei, W Shen, L Hu, K Yang - Small Methods, 2023 - Wiley Online Library
In cancer treatment, traditional radiotherapy (RT) is routinely conducted in local tumors and
limited by radioresistance, while recently emerged immunotherapy is confronted with low …

[HTML][HTML] Activation of autophagy by in situ Zn2+ chelation reaction for enhanced tumor chemoimmunotherapy

Y Yang, Y Zhu, K Wang, Y Miao, Y Zhang, J Gao… - Bioactive Materials, 2023 - Elsevier
Chemotherapy can induce a robust T cell antitumor immune response by triggering
immunogenic cell death (ICD), a process in which tumor cells convert from nonimmunogenic …

Targeting radiation-resistant prostate cancer stem cells by B7-H3 CAR T cells

Y Zhang, L He, A Sadagopan, T Ma, G Dotti… - Molecular cancer …, 2021 - AACR
Radiotherapy (RT) is a key treatment for prostate cancer. However, RT resistance can
contribute to treatment failure. Prostate cancer stem cells (PCSCs) are radioresistant. We …

Copper in cancer: from limiting nutrient to therapeutic target

X Tang, Z Yan, Y Miao, W Ha, Z Li, L Yang… - Frontiers in …, 2023 - frontiersin.org
As an essential nutrient, copper's redox properties are both beneficial and toxic to cells.
Therefore, leveraging the characteristics of copper-dependent diseases or using copper …